Your SlideShare is downloading. ×
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Outcomes Research
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Outcomes Research


Published on

Published in: Health & Medicine, Technology
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Letter of Intent Town Hall for Applicants August 2013 Cycle 1
  • 2. Agenda Introductions About PCORI PCORI Funding Announcements (PFA) Overview of PFA Merit Review Criteria Letter of Intent Overview Resources Live Q&A Submitting Questions: Submit questions via the chat function in Meeting Bridge Ask a question via phone (an operator will standby to take your questions) 2
  • 3. Introductions Martin Duenas, MPA Contracts Director James Hulbert Contracts Administrator Kirstin Margosian, MA Contracts Coordinator 3 Rachael Fleurence, PhD Program Director
  • 4. About PCORI 4
  • 5. PCORI’s Mission and Vision  The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health research organization authorized by the Patient Protection and Affordable Care Act of 2010.  PCORI funds patient-centered research to assist patients, caregivers, and other stakeholders in making informed health decisions. Mission PCORI helps people make informed healthcare decisions and improves healthcare delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers, and the broader healthcare community. Vision Patients and the public have the information they need to make decisions that reflect their desired health outcomes. 5
  • 6. Research Done Differently PCORI’s unique contribution to this field of research is its dedicated focus on outcomes that matter most to patients. Inclusion of patient-centered outcomes is therefore a necessary component of PCORI-funded research. PCORI involves patients and the entire healthcare community in every step of the research process — from selecting research questions to study, to the actual conduct of research, to sharing the research findings through platforms and channels that are accessible to everyone. 6
  • 7. PCORI Funding Announcements 7
  • 8. Overview of PFAs To solicit research proposals, PCORI regularly releases funding announcements that invite researchers to submit applications to receive funding to conduct research projects: Addressing Disparities Assessment of Prevention, Diagnosis, and Treatment Options Communication and Dissemination Research Improving Healthcare Systems Improving Methods for Conducting Patient-Centered Outcomes Research 8
  • 9. Improving Methods for Conducting Patient-Centered Outcomes Research 9
  • 10. Improving Methods for Conducting Patient-Centered Outcomes Research 10 In this PFA, we seek to fund projects that:  Improve methods for engaging patients/stakeholders in PCOR and for evaluating the impact of this patient/ stakeholder engagement.  Improve methods for systematic review of PCOR topics, including selection and prioritization of topics.  Improve the validity and/or efficiency of analytic methods and data sources utilized in PCOR research.  Improve methods to support the collection of Patient- Reported Outcomes and Patient-Centered Outcomes.  Improve methods to enhance the reproducibility, transparency, and replication of PCOR research.  Improve approaches for training researchers, patients, and other stakeholders in PCOR methods. Available funds: Up to $8 Million
  • 11. Studies PCORI Is Not Soliciting Under This PFA Studies whose primary focus is not on improving methods for PCOR: Studies should address gaps identified under the research areas of interest in the PFA and the Methodology Committee report. Studies whose primary focus is on developing or studying a disease-specific intervention, model, test, instrument, tool or other items without the primary objective being to address a methodological gap in PCOR as identified in the Methodology Committee report or in other recognized sources. Examples of non-responsive studies: 1. Study whose main focus is to evaluate the response to an intervention in patients with a specific disease. 2. Development of a tool to improve patient-physician communication around a difficult diagnosis. 11
  • 12. Broad Research Topics of Interest The following topics areas are areas of research that PCORI might be interested in:  Development of methods for patient-centeredness.  Research in methods to conduct systematic reviews of patient-centered CER.  Development of methods for generating, selecting, and prioritizing topics for research and for including patients and stakeholders in the peer-review process.  Development and refinement of general analytic methods.  Development and refinement of design-specific analytic methods.  Research that determines the validity and efficiency of data sources commonly used in PCOR.  Research related to Patient-Centered Outcomes (PCOs) and Patient-Reported Outcomes (PROs).  Research in methods to enhance the reproducibility, transparency, and replication of PCOR. 12
  • 13. Merit Review Criteria 13
  • 14. Merit Review Criteria Applicants must respond to the five PCORI Merit Review Criteria. 1. Impact on the field of PCOR methods 2. Potential for study to improve PCOR methods 3. Technical merit 4. Patient-centeredness 5. Patient and stakeholder engagement 14
  • 15. Criterion 1: Impact on the field of PCOR Methods Refers to the extent that the proposed methods are needed in the field of PCOR.  How often would these methods be used, and how many PCOR studies would benefit from these improved methods?  Do existing methods weaken the validity of PCOR studies, and would improved methods therefore increase the validity of PCOR findings? 15
  • 16. Criterion 2: Potential for study to improve PCOR Methods Refers to the potential of the proposed methodological investigation and its results to change methodological practices in ways that improve PCOR and the decisions made by patients.  Does the research question address a critical gap in current methodological understanding as noted in the Methodology Committee Report or in other sources?  Is the proposed approach feasible and likely to result in new standards or in the improvement of existing standards? 16
  • 17. Criterion 3: Technical merit Refers to the technical merit of the proposal.  Is there a clear research plan with rigorous methods and key milestones clearly articulated? Do the study methods reflect state-of the-art thinking and practice in the methodological area, so that results are likely to be accepted and heeded?  Is the research team appropriately trained and experienced to carry out the planned studies?  Is the research environment sufficient to support the conduct of the work, and are appropriate resources available?  Will the proposed methods help support the inclusion and study of diverse populations with respect to age, gender, race, ethnicity, geography, or clinical status, or, alternatively, do the methods support the inclusion of previously understudied populations in PCOR? 17
  • 18. Criterion 4: Patient-centeredness Refers to the level of patient-centeredness of the proposal.  Is the proposed methodological investigation specifically linked to improving PCOR methods, and specifically to the improved study of comparisons and patient- centered outcomes that are relevant and valued by patients, caregivers, and clinicians?  For relevant studies, how credible are the application’s claims that engaged patients and stakeholders will exert meaningful influence on the design and conduct of the research, to ensure patient-centeredness of the questions and outcomes addressed? 18
  • 19. Criterion 5: Patient and stakeholder engagement Refers to the level of engagement of patients and stakeholders in the proposed project.  Where applicable, applications need to demonstrate patient and stakeholder engagement through the integration of patients and stakeholders in the development of the research plan and in key elements of the proposed project including: • Participation in formulation of research questions • Defining essential characteristics of the study, participants, comparators, and outcomes • Monitoring study conduct and progress • Dissemination of research results  If the project has not included patient and stakeholder engagement (for example, in the area of analytic methods), has the application justified their non-inclusion? 19
  • 20. Letter of Intent (LOI) Submission: Deep Dive 20
  • 21. Understanding the Letter of Intent (LOI) A LOI is required in order to submit an application. LOI’s are NOT scored. Applicants will NOT receive an invitation to submit an application after submitting a LOI. An Investigator can only be listed as a PI on one. Of note: PCORI encourages applicants to submit their LOI and application before the stated due date. LOIs and applications are due 5:00 pm ET. 21
  • 22. Eligibility Requirements Applications may be submitted by:  Any private sector research organization, including any: • non-profit organization • for-profit organization  Any public sector research organization, including any: • university or college • hospital or healthcare system • Laboratory or manufacture • unit of state or local government  Foreign Organizations  Nondomestic Components of Organizations based in the United States Please Note: Individuals are not eligible to submit applications to PCORI. 22
  • 23. Budget and Period Limitations Budget • Maximum $250,000 direct costs per year • Indirect costs are capped at 40% • *Request for exception can be made during the LOI submission Period of Performance • Maximum of three years • PCORI encourages projects of shorter duration • *Request for exception can be made during the LOI submission *Of note: Approval or denial decisions may take up to four months. Please plan accordingly, and factor this into your decision to submit a request. 23
  • 24. Letter of Intent 24 The Letter of Intent includes:  Organizational information  Information about Key Personnel  Technical abstract (3,000 character limit) • Background: State the problem or methodological gap your research intends to address, including the rationale for tackling this problem. • Objectives: Briefly describe the specific aims of the study, including the methods gaps addressed. • Methods: Give a concise description of the steps involved in the development of the new methodology. • Anticipated impact: Describe the anticipated impact the study results will have on the field of PCOR methods. Of note: This abstract may be used to determine programmatic fit.
  • 25. Key Dates: August 15 2013 Key Dates: PCORI Funding Announcements Action August 2013 Cycle System Opening Date May 15 Letter of Intent (LOI) Due Date June 15 Informational Training Programs July – August Application Deadline August 15 Merit Review Dates September - November Awards Announced December / January Earliest Start Date January 25
  • 26. Frequently Asked Questions (Programmatic)  How do I know if my research is of interest to PCORI? • We encourage you to read the PCORI Funding Announcements (PFAs) carefully and other background material on our website to understand our goals and the PFA you are considering.  Can I speak with someone at PCORI about the suitability of my research question? • Currently, PCORI does not have dedicated individuals to speak with applicants regarding submission questions. Applicants and potential applicants with questions should submit those inquiries via  Is there a specific disease or condition that is a priority for PCORI? • No. PCORI is concerned with patient outcomes, across a range of conditions and treatments. PCORI will periodically issue PFAs that focus on specific diseases or conditions within or across funding areas. 26
  • 27. Frequently Asked Questions (Administrative)  Can I switch PFAs after a LOI has been submitted? • No. It is not possible to submit an LOI to one funding announcement and the full application to another.  How much can the research proposed in my application differ from that initially described in my Letter of Intent (LOI)? • The information provided in the LOI, including the study title, may be changed in the final application. Only two things may not differ: • The PFA may not change. • The budget may not exceed direct cost and/or project period, as listed within the PFA, if permission was not requested at LOI submission.  Can I list a different PI in the final application than was listed in the Letter of Intent (LOI)? • Yes. The PI listed on your final application may differ from the PI listed in the LOI. 27
  • 28. Resources 28
  • 29. Resources View training materials through the Quick Links for Applicants bar. Access: • Application training • Opportunities for webinars • Reviewer training Visit the Funding Center for: • PFAs • Templates • Instructions • Key dates • FAQ’s 29
  • 30. Questions Submitting Questions: Submit questions via the chat function in Meeting Bridge Ask a question via phone (press #7 on your phone) Please use this time to ask any question you may have about the PFA or the LOI submission process. If we are unable to address your question during this time, e-mail the help desk at 30